skip to Main Content
First Study of Private Legal Marijuana Investors


October 20, 2016

42% of these investors have made 5 or more investments, 71% expect to invest more in the future

Oakland, CAArcview Market Research, the leading publisher of cannabis market research, and The Arcview Investor Network, the leading private forum for high net worth accredited investors in partnership with New Frontier Data, the authority in cannabis Big Data and analytics, has released its 2016 Cannabis Investment Study: An Exclusive Look Into The Vanguard Investors of The Arcview Investor Network. The study unveils insights from members of this private forum of 550+ high net worth accredited investors who have placed more than $85 million behind 131 cannabis-related companies. Despite the relative infancy of the legal cannabis industry, 41% of the members of this group report making five or more investments already.

“The Arcview Investor Network is, by far, the largest single source of deal flow in the fastest growing industry in America and the largest single group of investors placing capital in the sector. We are excited to be the focus of the first ever deep-dive study on actual investor’s attitudes and actions so far.  What this data shows is that the cannabis industry is attracting droves of new investors to the world of angel and VC investing and that both new and experienced investors are diversifying across numerous companies. There are many interesting insights in this report that could have far reaching impacts for entrepreneurs raising capital and other investors considering placing bets in this sector,” said Arcview Group CEO Troy Dayton.

“It is notable to see investors’ appetite is now broadening beyond just ancillary services where there has been less stigma and risk attached in the past. With the cannabis industry being one of the fastest growing industries in the U.S., investors are now open to exploring any opportunity in the sector whether it touches the plant or not,” said New Frontier Data CEO and Founder Giadha DeCarcer in reference to 68% of respondents expressing some interest in investing in companies that touch cannabis.

Other key insights in this report include:

  • 65% of investors made their first investment in 2014 or later
  • 71% expect to invest more in 2016 than they did in 2015.
  • 26% of Arcview’s members have 25% or more of their portfolio in the cannabis sector
  • 42% of Arcview’s members have made 5 or more investments
  • 41% have invested $250,000 or more
  • 65% are new to angel/VC investing
  • 29% have donated $10,000 or more to the cannabis legalization effort

Some of the notable companies that these investors have invested in include:

Meadow, MJ Freeway, Steep Hill Labs, Mass Roots, Cannakorp, Cannasure, Front Range Biosciences, Wurk, Spare, Eaze, Green Broz, Grownetics, SPARC, Mjardin, Medicine Man, and Tokyo Smoke.

The report is downloadable at or and can be ordered for $399.

About The Arcview Group:

Founded in 2010, The Arcview Group is responsible for a number of groundbreaking ventures in the cannabis industry. The Arcview Investor Network includes more than 550+ dues-paying accredited investors who have put more than $85 million behind 131 companies. The next big members-only Arcview Investor Forum is scheduled for Las Vegas November 14-15. Arcview Market Research produces the State of Legal Marijuana Markets report, which is the most oft-cited market report. Arcview is a partner in Canopy, a seed-stage mentor-driven business accelerator. Arcview is also co-founder of Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry.  For more info on The Arcview Group please visit or contact Abby Benjamin at 720-518-7611 or [email protected].

About New Frontier Data:

New Frontier Data provides objective, rigorous and comprehensive analysis and reporting for the nascent and underserved cannabis industry. New Frontier’s data and reports have been cited in over 45 countries around the world to inform industry leaders. New Frontier, the premiere Big Data shop in the sector looks beyond the plant cultivation and distribution, to raise the industry bar and improve visibility into what will inevitably soon be a mature and more complex industry. Founded in 2014, New Frontier is headquartered in Washington, D.C. and has additional offices in Denver. For more information or media inquiries, please visit or contact Gretchen Gailey at 202-489-3821 or [email protected].

This Post Has One Comment

Leave a Reply

Your email address will not be published.

Recent Stories

Marijuana gifting parties are now illegal in Connecticut

Cannabis gifting parties are no longer allowed in Connecticut. Gov. Ned Lamont this week signed legislation that seeks to crack down on the unregulated cannabis bazaars that cropped up across Connecticut after the drug became fully legal here. At the events, attended by several thousand who usually paid a fee to get in, people would exchange items…

Anatomy of Curaleaf’s marijuana production blunder that sickened more than a dozen in Oregon: Here’s how it happened

A calamitous mix-up at a Portland marijuana bottling plant apparently originated with a single employee who confused two similar buckets with nearly identical identification numbers, according to a state investigative report. The report does not specify, though, whether manufacturer Curaleaf had any quality control measures in place to catch such mistakes, and state investigators withheld…

What you need to know about cannabis legalization in Rhode Island

PROVIDENCE — With a stroke of a pen, Rhode Island on Wednesday joined its two neighboring states and 16 others in legalizing the recreational use of marijuana. Less than 24 hours after lawmakers overwhelmingly passed the bill, Gov. Dan McKee signed the measure, which promises automatic expungement of past marijuana possession convictions and reserves a quarter of new…

Companies blanket Pa. with ads about how to get a medical marijuana card, but doctors are silenced

When Pennsylvania lawmakers legalized medical cannabis in 2016, they struck an unusual deal: Physicians can approve patients for the program but they are banned from advertising that power. Lawmakers feared advertising would encourage thousands of patients to flood the same doctor’s office solely seeking a medical marijuana card, or motivate physicians to excessively approve patients…

More Categories

Back To Top
×Close search